Stay updated on Gantenerumab in Early Alzheimer's Disease Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Early Alzheimer's Disease Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:53:05.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record instead of the usual content, indicating that access to the record is blocked.
    Difference
    18%
    Check dated 2026-09-22T22:52:23.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A new study location San Martin de Porres, Peru, 15102 was added and the San Martín de Porres entry was removed. The page revision was updated from v3.6.6 to v3.7.0.
    Difference
    0.0%
    Check dated 2026-09-15T20:55:33.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6 on the page, indicating a small maintenance/template update. The change does not modify any study text, eligibility criteria, locations, or outcome data.
    Difference
    0.0%
    Check dated 2026-09-01T19:27:43.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    A new NIH grant/contract reference (2017) was added, indicating funding information associated with the trial in the study’s identifiers.
    Difference
    0.0%
    Check dated 2026-08-25T16:57:39.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    A new publication citation by Tonietto et al. is added to the Publications section, expanding the study's referenced literature. The citation refers to a 2026 Alzheimer's Dement publication on gantenerumab and amyloid-related imaging abnormalities.
    Difference
    0.0%
    Check dated 2026-08-18T12:51:43.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Early Alzheimer's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.